1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotechnological Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Genetically Engineered Drugs
1.2.3 Therapeutic Monoclonal Antibody Drugs
1.2.4 Gene Therapy and Nucleic Acid Drugs
1.2.5 Genetically Engineered Vaccines
1.2.6 Other
1.3 Market by Application
1.3.1 Global Biotechnological Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Tumor
1.3.3 Autoimmune Disease
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Biotechnological Drugs Market Perspective (2017-2028)
2.2 Biotechnological Drugs Growth Trends by Region
2.2.1 Biotechnological Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biotechnological Drugs Historic Market Size by Region (2017-2022)
2.2.3 Biotechnological Drugs Forecasted Market Size by Region (2023-2028)
2.3 Biotechnological Drugs Market Dynamics
2.3.1 Biotechnological Drugs Industry Trends
2.3.2 Biotechnological Drugs Market Drivers
2.3.3 Biotechnological Drugs Market Challenges
2.3.4 Biotechnological Drugs Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Biotechnological Drugs Players by Revenue
3.1.1 Global Top Biotechnological Drugs Players by Revenue (2017-2022)
3.1.2 Global Biotechnological Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Biotechnological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biotechnological Drugs Revenue
3.4 Global Biotechnological Drugs Market Concentration Ratio
3.4.1 Global Biotechnological Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotechnological Drugs Revenue in 2021
3.5 Biotechnological Drugs Key Players Head office and Area Served
3.6 Key Players Biotechnological Drugs Product Solution and Service
3.7 Date of Enter into Biotechnological Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Biotechnological Drugs Breakdown Data by Type
4.1 Global Biotechnological Drugs Historic Market Size by Type (2017-2022)
4.2 Global Biotechnological Drugs Forecasted Market Size by Type (2023-2028) 5 Biotechnological Drugs Breakdown Data by Application
5.1 Global Biotechnological Drugs Historic Market Size by Application (2017-2022)
5.2 Global Biotechnological Drugs Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Biotechnological Drugs Market Size (2017-2028)
6.2 North America Biotechnological Drugs Market Size by Country (2017-2022)
6.3 North America Biotechnological Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada 7 Europe
7.1 Europe Biotechnological Drugs Market Size (2017-2028)
7.2 Europe Biotechnological Drugs Market Size by Country (2017-2022)
7.3 Europe Biotechnological Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Biotechnological Drugs Market Size (2017-2028)
8.2 Asia-Pacific Biotechnological Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Biotechnological Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia 9 Latin America
9.1 Latin America Biotechnological Drugs Market Size (2017-2028)
9.2 Latin America Biotechnological Drugs Market Size by Country (2017-2022)
9.3 Latin America Biotechnological Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Biotechnological Drugs Market Size (2017-2028)
10.2 Middle East & Africa Biotechnological Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Biotechnological Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE 11 Key Players Profiles
11.1 3SBIO
11.1.1 3SBIO Company Detail
11.1.2 3SBIO Business Overview
11.1.3 3SBIO Biotechnological Drugs Introduction
11.1.4 3SBIO Revenue in Biotechnological Drugs Business (2017-2022)
11.1.5 3SBIO Recent Development
11.2 Anhui Anke Biotechnology
11.2.1 Anhui Anke Biotechnology Company Detail
11.2.2 Anhui Anke Biotechnology Business Overview
11.2.3 Anhui Anke Biotechnology Biotechnological Drugs Introduction
11.2.4 Anhui Anke Biotechnology Revenue in Biotechnological Drugs Business (2017-2022)
11.2.5 Anhui Anke Biotechnology Recent Development
11.3 Beijing SL Pharmaceutical
11.3.1 Beijing SL Pharmaceutical Company Detail
11.3.2 Beijing SL Pharmaceutical Business Overview
11.3.3 Beijing SL Pharmaceutical Biotechnological Drugs Introduction
11.3.4 Beijing SL Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
11.3.5 Beijing SL Pharmaceutical Recent Development
11.4 Biotech Pharmaceutical
11.4.1 Biotech Pharmaceutical Company Detail
11.4.2 Biotech Pharmaceutical Business Overview
11.4.3 Biotech Pharmaceutical Biotechnological Drugs Introduction
11.4.4 Biotech Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
11.4.5 Biotech Pharmaceutical Recent Development
11.5 Cadila Healthcare
11.5.1 Cadila Healthcare Company Detail
11.5.2 Cadila Healthcare Business Overview
11.5.3 Cadila Healthcare Biotechnological Drugs Introduction
11.5.4 Cadila Healthcare Revenue in Biotechnological Drugs Business (2017-2022)
11.5.5 Cadila Healthcare Recent Development
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Company Detail
11.6.2 Celgen Biopharma Business Overview
11.6.3 Celgen Biopharma Biotechnological Drugs Introduction
11.6.4 Celgen Biopharma Revenue in Biotechnological Drugs Business (2017-2022)
11.6.5 Celgen Biopharma Recent Development
11.7 Celltrion
11.7.1 Celltrion Company Detail
11.7.2 Celltrion Business Overview
11.7.3 Celltrion Biotechnological Drugs Introduction
11.7.4 Celltrion Revenue in Biotechnological Drugs Business (2017-2022)
11.7.5 Celltrion Recent Development
11.8 Dr Reddy?s
11.8.1 Dr Reddy?s Company Detail
11.8.2 Dr Reddy?s Business Overview
11.8.3 Dr Reddy?s Biotechnological Drugs Introduction
11.8.4 Dr Reddy?s Revenue in Biotechnological Drugs Business (2017-2022)
11.8.5 Dr Reddy?s Recent Development
11.9 GeneScience Pharmaceuticals
11.9.1 GeneScience Pharmaceuticals Company Detail
11.9.2 GeneScience Pharmaceuticals Business Overview
11.9.3 GeneScience Pharmaceuticals Biotechnological Drugs Introduction
11.9.4 GeneScience Pharmaceuticals Revenue in Biotechnological Drugs Business (2017-2022)
11.9.5 GeneScience Pharmaceuticals Recent Development
11.10 Hisun Pharma
11.10.1 Hisun Pharma Company Detail
11.10.2 Hisun Pharma Business Overview
11.10.3 Hisun Pharma Biotechnological Drugs Introduction
11.10.4 Hisun Pharma Revenue in Biotechnological Drugs Business (2017-2022)
11.10.5 Hisun Pharma Recent Development
11.11 Jiangsu Sihuan Bioengineering
11.11.1 Jiangsu Sihuan Bioengineering Company Detail
11.11.2 Jiangsu Sihuan Bioengineering Business Overview
11.11.3 Jiangsu Sihuan Bioengineering Biotechnological Drugs Introduction
11.11.4 Jiangsu Sihuan Bioengineering Revenue in Biotechnological Drugs Business (2017-2022)
11.11.5 Jiangsu Sihuan Bioengineering Recent Development
11.12 Novartis (Sandoz)
11.12.1 Novartis (Sandoz) Company Detail
11.12.2 Novartis (Sandoz) Business Overview
11.12.3 Novartis (Sandoz) Biotechnological Drugs Introduction
11.12.4 Novartis (Sandoz) Revenue in Biotechnological Drugs Business (2017-2022)
11.12.5 Novartis (Sandoz) Recent Development
11.13 Pfizer (Hospira)
11.13.1 Pfizer (Hospira) Company Detail
11.13.2 Pfizer (Hospira) Business Overview
11.13.3 Pfizer (Hospira) Biotechnological Drugs Introduction
11.13.4 Pfizer (Hospira) Revenue in Biotechnological Drugs Business (2017-2022)
11.13.5 Pfizer (Hospira) Recent Development
11.14 Shanghai Lansheng Guojian Pharmaceutical
11.14.1 Shanghai Lansheng Guojian Pharmaceutical Company Detail
11.14.2 Shanghai Lansheng Guojian Pharmaceutical Business Overview
11.14.3 Shanghai Lansheng Guojian Pharmaceutical Biotechnological Drugs Introduction
11.14.4 Shanghai Lansheng Guojian Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
11.14.5 Shanghai Lansheng Guojian Pharmaceutical Recent Development
11.15 Shenzhen Neptunus Interlong Bio-Technique
11.15.1 Shenzhen Neptunus Interlong Bio-Technique Company Detail
11.15.2 Shenzhen Neptunus Interlong Bio-Technique Business Overview
11.15.3 Shenzhen Neptunus Interlong Bio-Technique Biotechnological Drugs Introduction
11.15.4 Shenzhen Neptunus Interlong Bio-Technique Revenue in Biotechnological Drugs Business (2017-2022)
11.15.5 Shenzhen Neptunus Interlong Bio-Technique Recent Development
11.16 Tonghua Dongbao Pharmaceutical
11.16.1 Tonghua Dongbao Pharmaceutical Company Detail
11.16.2 Tonghua Dongbao Pharmaceutical Business Overview
11.16.3 Tonghua Dongbao Pharmaceutical Biotechnological Drugs Introduction
11.16.4 Tonghua Dongbao Pharmaceutical Revenue in Biotechnological Drugs Business (2017-2022)
11.16.5 Tonghua Dongbao Pharmaceutical Recent Development
11.17 Torrent Pharmaceuticals
11.17.1 Torrent Pharmaceuticals Company Detail
11.17.2 Torrent Pharmaceuticals Business Overview
11.17.3 Torrent Pharmaceuticals Biotechnological Drugs Introduction
11.17.4 Torrent Pharmaceuticals Revenue in Biotechnological Drugs Business (2017-2022)
11.17.5 Torrent Pharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
